Use of centrally developed pharmacoeconomic assessments for local formulary decisions

June M. Tordoff, John E. Murphy, Pauline T. Norris, David M. Reith

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Purpose. The distribution, content, timeliness, use, and influence of pharmacoeconomic assessments (PEAs) of drugs in New Zealand public hospitals were examined, Methods. In April 2005, a questionnaire-based, cross-sectional survey was sent to chief pharmacists at all 29 New Zealand hospitals employing a pharmacist. The questionnaire asked pharmacists about the use and influence of PEAs. In their hospitals' formulary decision-making process. Answers were given using a scale of 1 to 6, with 1 being the most positive response, Results. Of the 29 surveys mailed, 24 (83%) were completed. Data on 12 PEAs were analyzed. Assessments were seen and summaries read in most hospitals (median, 77% and 65%, respectively). Full documents were read in fewer hospitals (35%). In general, the PEAs were considered moderately easy to understand, provided a concise summary, and contained adequate detail of the methodology. Of the 24 respondent hospitals, 21 had assessment processes for new medicines; hence, a total of 252 hospital evaluations of Pharmaceutical Management Agency (PHARMAC)-assessed drugs were possible. A total of 132 possible evaluations (52%) were undertaken. More evaluations (106 [42%]) took place before PHARMACs PEAs were distributed and fewer (26 [10%]) after distribution. Where used, the PEAs appeared to have a modest effect on hospital decisions. Conclusion. The provision of 12 PEAS by PHARMAC to hospitals in New Zealand had only a modest influence on their formulary decision-making process, mostly due to the lack of timeliness of the PEAs. The timely delivery of centrally developed PEAs may be essential to generating a greater effect on the formulary decisions at a wider level.

Original languageEnglish (US)
Pages (from-to)1613-1618
Number of pages6
JournalAmerican Journal of Health-System Pharmacy
Issue number17
StatePublished - Sep 1 2006


  • Data collection
  • Decision-making
  • Formularies
  • Hospital
  • Institutional
  • Methodology
  • Pharmacoeconomics
  • Pharmacy

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy


Dive into the research topics of 'Use of centrally developed pharmacoeconomic assessments for local formulary decisions'. Together they form a unique fingerprint.

Cite this